24-Week Recurrence Rate of Gout Following Firsekibart Treatment

NCT07625514 · clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
264
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Second Affiliated Hospital, Zhejiang University, School of Medicine